Featured Resources

Introducing: LifeScienceXchange

Patients are counting on your R&D community for the next wave of life-saving medicines.

LifeScienceXchange is the catalyst: a platform for leaders from diverse life science disciplines to connect, learn and collaborate, so that together we bring new treatments to patients faster, sustainably and at scale.

Providing actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format.

It will help you understand trends, benchmark your work, inform strategy and ultimately get your new treatments to patients, faster.

Precision Medicine on LifeScienceXchange provides the events and channels for R&D to unlock human data for precise, patient-centric solutions.

LSX Logo - Better Patient Slogan

Learn faster and put new ideas to work

Market Insights unlock key learnings and actionable ideas from our industry-leading live events. We’ve cut and curated more than 6,000 hours of live recordings into quick-watch cuts, so you can get straight to the moments that matter.

Innovate sooner and benchmark success

Our Technology Showcases give you first sight of the breakthroughs driving our industry. We put you in touch with new developments and vendor success stories, so you can understand the tech, connect with the innovators and benchmark your work against the best

Learn and share ideas with industry leaders

Our Thought Leadership opportunities put you at the heart of the conversations accelerating life sciences R&D today. Hear interviews and presentations with key opinion leaders each month — and join the conversation by putting your questions to them live.

Get the full picture faster

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. Each week we identify and summarise the five top stories in quick-read format, so you have a full, clear and balanced picture.

Genome Editing

Full Human Gene-Replacement Mouse Models & The Future Of Neurodegenerative Treatments

In Conversation With Mike Koob, Associate Professor in the Department of Laboratory Medicine and Pathology at the University of Minnesota
Clinical Development

Using Biomarkers For Clinical Development and Regulatory Approval

Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our February Discussion Group, focusing on ‘Using Biomarkers For Clinical Development & Regulatory Approval,’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
Clinical Development

Transforming Clinical Development with Biomarkers

How can the industry transform itself with improved biomarkers for clinical development? And what hurdles stand in the way? We sat down with senior representatives from Galapagos, Ohio State University, and Genentech to find out more.
Clinical Development

The Patient-focused ‘Paradigm Shift’ That Could ‘Revolutionise’ Clinical Trials

Melanie Anderson, Principal Scientist at MSD, on how the pandemic has made scientists rethink clinical trials.
Single Cell Analysis

Single Cell Transcriptomics: Computational Analysis and Data Normalisation

Due to the heterogeneity seen in both eukaryotic and prokaryotic cell populations, single cell analysis opens up many new possibilities.
Spatial Analysis

The Molecular Landscape of SARS CoV 2 Infection in Tissue - A Multi Omic Approach

Presented by Tony Zucca, NanoString Technologies & Matthew Pugh, University of Birmingham
Spatial Analysis

Spatial Omics: Advancements and Use

Spatial omics is changing how we think about biology, giving us an unprecedented view into single cells and tissues.
Genome Editing

Synthetic Gene Circuits & Their Relevance To The Challenges Of Genome Editing

In Conversation With Gabor Balazsi, Henry Laufer Professor, Stony Brook University
Biomarker Discovery & Development

Implementing Flow Cytometry Assays In Biomarker Research

Oxford Global’s Discussion Groups provide a focused networking opportunity for a select group of like-minded experts on a monthly basis. Our first Biomarkers Discussion Group addressing ‘Implementing Flow Cytometry Assays In Biomarker Research’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
DPCR

Using ddPCR to Assess Gene Editing Therapies

When gene therapy goes wrong, it can have severe consequences. Dr Giandomenico Turchiano tells us how he can use ddPCR to catch those mistakes
Digital Biomarkers

Digital Biomarkers – An Industry Game Changer

This commentary article looks at the latest applications in digital and wearable biomarkers, with industry and academic insights from GlaxoSmithKline, Roche, and University College London.
Spatial Analysis

Spatial Genomics with Illumina Sequencing & NanoString GeoMx® Digital Spatial Profiler

Presented by Wes Goldman, NanoString | Bo Liu, Illumina | Cynthia Lebeaupin, Sanford Prebys Medical Discovery Institute | Jessica Noll, UC Riverside

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery